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RESUMEN 
Objetivo: Desarrollar un instrumento para 
la evaluación del desempeño de la atención 
primaria a la salud en la puesta en marcha 
de las acciones de control de la hanseniasis 
bajo la perspectiva de los usuarios y realizar 
la validación de cara y contenido. Método: 
Se trata de un estudio metodológico lleva-
do a cabo en cuatro etapas: desarrollo del 
instrumento, validación de cara y de con-
tenido, pre-prueba y análisis de la confia-
bilidad de prueba-reprueba. Resultados: El 
instrumento inicial, sometido al juicio de 
15 expertos, estaba compuesto de 157 íte-
ms. La validación de cara, contenido y pre-
prueba del instrumento fue fundamental 
para la exclusión de ítems y la adecuación 
del instrumento para evaluar el objeto de 
estudio. En el análisis de confiabilidad de 
prueba-reprueba, el instrumento se mos-
tró fehaciente. Conclusión: Se considera 
el instrumento adecuado, pero son nece-
sarios nuevos estudios para el test de las 
propiedades psicométricas.
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RESUMO 
Objetivo: Desenvolver um instrumento 
para avaliação do desempenho da atenção 
primária à saúde na realização das ações 
de controle da hanseníase na perspecti-
va dos usuários e realizar a validação de 
face e conteúdo. Método: Trata-se de um 
estudo metodológico realizado em quatro 
etapas: desenvolvimento do instrumento, 
validação de face e de conteúdo, pré-teste 
e análise da confiabilidade teste-reteste. 
Resultados: O instrumento inicial, subme-
tido ao julgamento de 15 especialistas, 
era composto por 157 itens. A validação 
de face, conteúdo e pré-teste do instru-
mento foi fundamental para a exclusão de 
itens e adequação do instrumento para 
avaliar o objeto em estudo. Na análise de 
confiabilidade teste-reteste, o instrumento 
mostrou-se fidedigno. Conclusão: O instru-
mento é considerado adequado, mas são 
necessários novos estudos para o teste das 
propriedades psicométricas.
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ABSTRACT 
Objective: Developing an instrument to 
evaluate the performance of primary he-
alth care in the leprosy control actions, 
from the perspective of users and do the 
face and content validation. Method: This 
is a methodological study carried out in 
four stages: development of instrument, 
face and content validation, pre-test, and 
analysis of test-retest reliability. Results: 
The initial instrument submitted to the 
judgment of 15 experts was composed of 
157 items. The face and content validation 
and pre-test of instrument were essential 
for the exclusion of items and adjustment 
of instrument to evaluate the object under 
study. In the analysis of test-retest reliabi-
lity, the instrument proved to be reliable. 
Conclusion: The instrument is considered 
adequate, but further studies are needed 
to test the psychometric properties.
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INTRODUCTION
Leprosy is an infectious disease of slow evolution caused 
by the bacillus Mycobacterium leprae, which is mainly man-
ifested by dermatological and neurological symptoms and 
signs(1). Approximately 33 thousand new cases are diag-
nosed each year in Brazil(2), and if the leprosy is not timely 
diagnosed and treated, it can lead to restricted social life 
and physical, psychological and economic problems(3).
The National Leprosy Control Program of the Ministry of 
Health recommends that the model of care for the disease - 
based on early diagnosis, timely treatment, prevention and 
treatment of physical disabilities and surveillance of contacts 
- runs across the whole network of primary health care (PHC), 
with the support of secondary and tertiary care to reduce the 
endemic levels of disease and ensure quality of care(4).
According to the National Policy for Primary Care(5), 
the primary care is responsible for managing the most fre-
quent and relevant health needs in the territory, conduct-
ing actions in health promotion, protection from diseases, 
diagnosis, treatment and rehabilitation at individual and 
collective levels. However, studies show that Brazilian 
municipalities still face difficulties in integrating the lep-
rosy control actions (LCA) in the PHC(6-8), both at individual 
level, due to lack of trained professionals to diagnose and 
treat, as at the collective level, with the completion of 
specific educational activities for the community, search 
for contacts and epidemiological surveillance(8).
To ensure improved access and quality of health care 
in the Unified Health System (SUS), the Ministry of Health 
(MOH) implemented the National Program for Improving 
Access and Quality of Primary Care (Pmaq – Programa Na-
cional de Melhoria do Acesso e da Qualidade da Atenção 
Básica) in 2011, which contemplates leprosy in the list of 
full attention to the Brazilian population that should be 
offered by the PHC(9). In the self-assessment stage of the 
Pmaq, professionals and managers are asked to identify 
the problems of the work process in the PHC, and the 
intervention strategies. However, the inclusion of users 
in this evaluation process would be desirable due to un-
derstanding that all are jointly responsible for the quali-
fication of the SUS. The Pmaq manual presupposes that 
teams can use other tools that better fit the raising of 
problems and bring a more appropriate reflection about 
the health needs of the population(9).
Accordingly, we have the PHC Assessment Tool avail-
able (Primary Care Assessment Tool - PCATool-Brasil(10)), 
adult users version. It assesses the presence and extent of 
the PHC attributes - first contact (access and use), longi-
tudinality, coordination (of care and information system), 
comprehensiveness (services available and services pro-
vided), family approach and community orientation – in 
the experience of adult users of PHC services(11).
Currently, managers and professionals use the epide-
miological and operational indicators of leprosy(4) as tools to 
evaluate the disease control program. Since in the literature 
there is no validated instrument that assesses the attributes 
of PHC in the care of leprosy, the study aimed to develop an 
instrument for evaluating the performance of primary care 
services in the LCA from the perspective of users, and do the 
face and content validation.
METHOD
This is a methodological study carried out in four stag-
es, namely: development of instrument, face and content 
validation, pre-test and analysis of test-retest reliability.
Stage 1: Development of instrument
The construction of the Instrument for assessing the 
performance of primary care in efforts for leprosy control - 
user version was based on the framework of PHC in Brazil(12) 
and in efforts for leprosy control performed at this level of 
health care(4,13). After the literature review, the instrument 
had 157 items divided into seven constructs: first contact 
(4), access (39), continued care (23), comprehensiveness 
of available and provided services (51), coordination (14), 
family orientation (14) and community orientation (12).
For the wording of questions, development of re-
sponse alternatives and score calculation of the attributes, 
the format used in the PCATool-Brazil(10) was taken into 
consideration. The users answered the instrument ques-
tions according to the options: 1 (definitely not); 2 (prob-
ably not); 3 (probably); 4 (definitely); 9 (do not know/can-
not remember) and 88 (not applicable - code inserted in 
items if the user has not had leprosy reactions, referral to 
a specialist and discharge due to cure). It is noteworthy 
that the items with dichotomous responses - yes/no – are 
not included in the score calculation of the attributes.
Stage 2: Face and content validation
The judgment of the adequacy of the instrument items 
was done by two expert committees, which included the 
participation of 15 professionals with experience in man-
agement, education and assistance in leprosy or in the 
area of primary health care. The items were analyzed for 
content (suitability to the theoretical concept - the PHC 
attributes - and to the object that is to be measured – per-
formance of the LCA in the PHC), clarity, need for exclud-
ing and adding new items. This evaluation took place in 
person and by mail in March and April 2012.
In the first panel, five experts assessed the adequacy of 
the instrument items in relation to the object of study when 
answering the question: Are the contents measured by this 
question essential/useful/not essential to evaluate the orga-
nizational and performance characteristics of primary health 
care services in the care of leprosy? Items with less than 80% 
of positive responses (essential and useful) were excluded(14).
In the second panel, the experts judged if the content of 
the item was properly related to the theoretical concept of 
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the respective PHC attribute and a qualitative assessment 
of each analysis of the questionnaire items was carried out.
Stage 3: Pre-test of instrument
The version of the instrument designed after the judg-
ment of the expert committee, was subjected to a pre-test in 
the city of Betim (MG), in June and July 2012 to analyze the 
instrument adequacy: if the items are clear, understandable 
and relevant to reach the study objective, as well as the time 
required for the questionnaire application. In total, 23 users 
who underwent treatment of leprosy in PHC units participat-
ed in the pilot study. Participants were instructed to answer 
the questions according to the care received during the pe-
riod of leprosy treatment, and to indicate any difficulties with 
understanding the questions and the range of responses. 
The factors facilitating and hindering the instrument appli-
cation were discussed at a meeting of the research group, 
which resulted in the drafting of the instrument final version.
Stage 4: Test-retest reliability
For the reliability assessment, the instrument final ver-
sion with 109 items was applied in two endemic munici-
palities of Minas Gerais - Almenara and Governador Va-
ladares. The reliability was checked by the time stability, 
resulting from the questionnaire application at two differ-
ent times (test-retest reliability), 30 days after the end of 
data collection, in 10% of the sample. The Wilcoxon test 
with significance level of 5% was used to assess whether 
there were differences in the responses obtained in the 
test and retest.
The convenience sample consisted of all leprosy pa-
tients reported between the years 2009 and 2012 who 
underwent the treatment exclusively in PHC health units 
and agreed to participate in the study. Patients aged un-
der eighteen years, adults with special problems, patients 
in the prison and residents in rural areas were excluded. 
Data were collected through an interview conducted at 
the home of participants or at the health unit during the 
period between July and December 2012.
The database was built using the EPI-INFO software 
(version 7) and, after the data entry, the values of the 
items C3, C4, C5 and C8 were reversed, as they were for-
mulated in order that the higher the value of assigned re-
sponse, the fewer the guidelines for PHC. The Statistical 
Package for the Social Sciences (SPSS) for Windows 17 was 
used for statistical analysis.
Ethical aspects
The research project was approved by the Research Eth-
ics Committee (COEP) of the Universidade Federal de Minas 
Gerais under number ETIC 0095.0.203.000-11. All survey 
participants – the experts and the leprosy patients from 
the municipalities of Betim, Almenara and Governador Va-
ladares - agreed to participate in the study and signed the 
Free and Informed Consent Form (ICF) in duplicate.
RESULTS
The evaluation of the questionnaire items regarding 
relevance, clarity, understanding and adequacy of the 
item to the PHC attribute was made by 15 experts in the 
two major areas of the instrument: leprosy and primary 
health care. Nine doctors, five nurses and a biologist par-
ticipated in this stage, considering that 66.6% (n = 10) 
have stricto sensu post-graduate studies and 26.7% (n = 4) 
have lato sensu post-graduate studies.
The first panel of experts assessed that only five of the 
157 items were not essential to evaluate the performance 
of PHC in leprosy control and suggested the inclusion of 
six items, as well as the semantic change of 17 items for 
better understanding. After the discussion of these find-
ings by researchers, the following changes were made 
in the instrument: exclusion and semantic changes of all 
items suggested by the experts, and inclusion of only four 
items in the instrument version submitted to the judg-
ment of the second panel. In this latest assessment, the 
instrument consisted of 156 items and were suggested 
the exclusion of 28 items, change of 25 domain items 
(PHC attributes) and inclusion of 11 items. After this stage, 
the user version of the instrument for evaluating the per-
formance of primary care in the actions of leprosy control 
applied in the pilot study in the city of Betim, was com-
posed of 139 items.
The pilot study carried out with 23 users (Table 1), 
was essential to understand that 32 items of the instru-
ment were inadequate to evaluate the performance of 
PHC in the care of leprosy and include a new domain of 
the instrument called ‘degree of affiliation’ with seven 
questions, a question in the attribute ‘continued care’ and 
another in the construct ‘comprehensiveness of available 
services’. After evaluating the results of the pre-test, the 
instrument was considered appropriate to measure the 
object under study and was applied to 31 users who un-
derwent the leprosy treatment in PHC units in the munici-
palities of Almenara and Governador Valadares (Table 1). 
Table 1 - Characterization of the study sample - Betim, Almenara, 
Governador Valadares, 2012
Variables
Betim Almenara Governador Valadares
(n=23) (n=24) (n=7)
Gender (n):
Female 8 8 6
Male 15 16 1
Years of study (n):
No education 3 10 4
Up to 7 years 15 11 1
8 to 10 years 4 3 1
More than 11 years 1 0 1
Year of notification (n):
2012 8 4 0
2011 5 7 1
2010 7 6 0
2009 3 7 6
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In the application of the instrument in this scenario, it 
was found that the scale of response, of the Likert type, 
could hold only three options, since the answers were po-
larized in the alternatives of definitely and certainly not. 
Thus, it can be inferred that the respondent did not un-
derstand the differences in degree among the options for 
definitely and probably.
The construct validation was done mirrored on the 
version for the community health agents (CHA)(15), since 
the sample of 380 CHA was suitable for exploratory fac-
tor analysis. At this stage, five items of the user version 
were excluded, therefore, the final instrument consisting 
of 104 items was assessed for reliability. In the reliability 
analysis, it was not possible to determine the internal con-
sistency by Cronbach’s alpha due to the insufficient size of 
the sample (31 users). The result of the temporal stability 
of the instrument is shown in table 2.
of instrument obtained after the experts’ judgment. Authors 
suggest that the pre-test should take place in a location with 
characteristics similar to those of the final scenario of ques-
tionnaire application(16). This step was essential to assess the 
adequacy of the response card, reduce the number of items 
in the instrument, and improve understanding of questions. 
Thus, the first stage of the test validation was obtained, be-
cause the items remaining in the instrument were considered 
relevant to represent the latent trait(17) that in this case, is the 
performance of PHC in carrying out leprosy control actions.
Since this is a small sample (only 31 users), it was not 
possible to conduct the exploratory factor analysis (which re-
duces the set of items in the instrument to a size that retains 
as much information as possible(18)) and the analysis of the 
internal consistency of items (which assesses the homogene-
ity of scales in items that can be answered in more than two 
alternatives(18)). A sample five times greater than the number 
of items to be evaluated would be necessary to evaluate the 
validity and accuracy of the instrument(18). However, the re-
sults of the test-retest reliability, which are also a measure 
of reliability of a test, showed that the instrument for the 
leprosy patients is precise and measured identical scores of 
the same respondents in two different moments in time(17-18). 
Thus, the instrument showed here has the characteristic of 
measuring without mistakes, and to evaluate this accuracy 
was chosen the same methodology used in the validation of 
the PCATool-Braszil, adult version(11).
As the version of the instrument for the CHA is valid to 
evaluate the performance of primary care in leprosy con-
trol(15), for the user version was carried out a mirror valida-
tion. This resource was also used for presenting the profes-
sional version of the PCATool-Brazil that although still had its 
validation process in progress, was also recommended for 
mirror use in the version for adult users(10). The authors de-
sign the application of the instrument in patients undergo-
ing treatment of leprosy in the municipalities of the metro-
politan Region of Belo Horizonte to examine the validity and 
accuracy by the methodology of the Classical Test Theory, 
which aims to produce quality tests(17).
CONCLUSION
We conclude that the instrument is considered ad-
equate for evaluating the performance of PHC in the de-
velopment of efforts for leprosy control according to the 
users’ experience, after analysis by the expert committee 
and the preliminary test of adjustments. Future studies 
are suggested to refine the quality of the instrument so it 
can be widely used in health services as an evaluative tool 
to complement the Pmaq questionnaire.
Table 2 - Evaluation of the test-retest stability of the PHC attributes 
that make up the final version of the instrument for users - Almena-
ra, Governador Valadares, 2012
Instrument attributes Wilcoxon test (p value)
Degree of affiliation - PHC 0.317
First contact 1.000
Access 0.180
Continued care 0.705
Comprehensiveness of available services 1.000
Comprehensiveness of provided services 0.144
Coordination 0.180
Family orientation 0.655
Community orientation 0.581
Regarding reliability, which was partially evaluated, it 
was found that the scores of all the instrument attributes 
remained stable in the test and retest. However, further 
studies are required to carry out the validation of the final 
instrument (shown in Appendix) by the methodology of 
Classical Test Theory.
DISCUSSION
The panel of experts analyzed the initial draft of the in-
strument, and the face and content assessment of the ver-
sion for users was satisfactory, because there was a semantic 
change for adequacy of clarity and understanding(16), inclu-
sion/exclusion of items and change of domains (PHC attri-
butes) to ensure that the instrument is capable of capturing 
the content proposed in the research(16). The pilot study al-
lowed checking in practice the performance of the version 
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APPENDIX
Items of the final version of the ‘Instrument for assessing the performance of primary care in efforts for leprosy control - user version’.
PHC attributes and instrument items
DEGREE OF AFFILIATION (OPEN QUESTIONS)
A1. In which health unit are your registered?
A2. Which health unit is the most responsible for your care?
A3. Which health unit do you normally visit when you get sick?
A4. What was the first health service you sought when you started having the symptoms of leprosy?
A5. What was the health service that found (diagnosed) you had leprosy?
A6. Which health service do/did you visit for your leprosy treatment?
Do/Did you use prednisone or thalidomide?  (   ) Yes  (   ) No.  If YES, answer question A.7
A7. In which health service were you served?
FIRST CONTACT
B1. Was the primary health care unit the first place you looked for when you presented the signs and symptoms of leprosy?
B2. Do/Did you look for the primary health care unit for the examination of your family and guidance on caring for your eyes, hands and feet for 
prevention of disabilities?
B3. When you need (or needed) an appointment due to a new health problem related to leprosy (such as the appearance of new spots, pain in the 
peripheral nerves and others), do/did you look for the primary health care unit?
B4. Did you need to attend a consultation in the primary health care unit to be referred for an evaluation with a leprosy specialist (Ex.: dermatolo-
gist)?
ACCESS
C1. Is the health unit open after 6PM at least one day during the week?
C2. When the unit is open, is there a phone number to call for information?
C3. Is reaching the health unit difficult for you?
C4. Do you have to use the bus, car or bike to get to the health unit?
C5. Do you miss your work shift to be served at the health unit?
C6. When you looked for the health unit with complaints of leprosy symptoms, did you manage to see a doctor or a nurse within 24 hours?
C7. Do you schedule an appointment at the health unit to receive the supervised dose?
C8. When you come to the health unit, do you have to wait longer than 30 minutes to receive the supervised dose?
C9. Did you manage to schedule an appointment at the health unit within 24 hours when you had a new health problem related to leprosy (Ex.: 
nerve pain, medication reactions, leprosy reactions)?
CONTINUED CARE 
D1. When you go to the health unit for a leprosy consultation, are you seen by the same doctor at all times?
D2. When you go to the clinic for a leprosy consultation, are you seen by the same nurse at all times?
D3. Does the doctor or nurse have your medical records available during your consultation?
D4. During your consultation, does the doctor or nurse make notes on the details of your appointment in your medical record?
D5. Does the doctor or nurse know your whole health history (Ex.: other diseases you have or had or surgeries)?
D6. Does the doctor or nurse ask about all medicines that you are taking?
D7. Does the doctor or nurse ask if you have trouble paying for drugs not provided by the SUS and other products that you need?
D8. If you have any questions about the illness or doubts about the treatment, can you speak with the doctor or nurse that works at the health unit?
D9. Does the doctor or nurse answer your questions in a way that you understand?
D10. Does the doctor or nurse give you enough time to talk about your concerns and answer your questions?
D11. Does the doctor or nurse ask if leprosy makes it difficult to perform activities of your daily life?
D12. Does the doctor or nurse know about your work?
D13. Are you satisfied with the service of the health unit?
COMPREHENSIVENESS OF AVAILABLE SERVICES
Are the following services available at the primary health care units?
E1. Vaccines 
E2. Care for children
E3. Care for adolescents
E4. Care for adults
E5. Care for the elderly
E6. Family planning or contraceptive methods
E7. Prenatal care
E8. Screening test for cancer of the cervix
E9. Care for sexually transmitted diseases, including counseling and request for HIV testing
Continued...
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E10. Care for schistosomiasis, dengue and tuberculosis
E11. Care for hypertension, diabetes and asthma
E12. Care for mental health problems
E13. Dressings
E14. Counseling or treatment for harmful use of tobacco
E15. Advice on healthy eating
E16. Evaluation of oral health and dental treatment
E17. Home care
COMPREHENSIVENESS OF PROVIDED SERVICES
In relation to leprosy, does/did the health unit provide those services?
E18. Guidance on what is leprosy and how to catch the disease
E19. Skin assessment with the sensitivity test (warm/cold)
E20. Skin assessment with the sensitivity test with cotton
E21. Skin assessment by performing the monofilament testing (esthesiometer)
E22. Palpation of peripheral nerves
E23. Test sensitivity of the hands and feet with the use of monofilaments (esthesiometer)
E24. Test sensitivity of the eyes with the use of dental unflavored floss
E25. Assessment of motor strength
E26. Assessment of visual acuity by applying the Snellen chart
E27. Request for blood tests in the beginning of leprosy treatment
E28. Smear testing in the city
E29. Assessment of people who live with you (contacts examination)
E30. Application of the BCG vaccine in people who live with you
E31. Monthly consultation to evaluate your health when you go to the health unit to receive the supervised dose
E32. Guidance on the proper use of medication for leprosy and the major reactions caused by them
E33. Guidance on the care of the eyes, hands and feet
E34. Guidance on the signs and symptoms of leprosy reactions: the appearance of new spots on the skin, nerve pain and decreased motor strength
E35. Sensitivity testing of eyes, hands and feet and evaluation of muscle strength every three months
E36. Offering of other services available at the health unit
Answer questions E37 and E38 only if patient was discharged. 
Does not apply in other cases.
E37. Perform sensitivity testing of eyes, hands, feet and evaluation of muscle strength at the end of treatment
E38. Guidance on care after discharge for healing, such as the periodic monitoring by professionals and maintaining care of the eyes, hand and feet
If the respondent answered the question A7, answer the questions E39 to E43.
E39. Palpation of peripheral nerves, muscle strength testing, sensitivity testing of eyes, hands and feet, fortnightly or monthly
E40. Guidance to place the affected limb at rest
E41. Initiation of treatment with prednisone at the health unit
E42. Referral to the reference service
E43. Regular monitoring of fasting glucose (blood glucose), body weight and blood pressure during treatment with prednisone
COORDINATION
Only respond if the patient has been referred to a specialist.
Does not apply in other cases.
F1. After scheduling the appointment with a specialist, have you received any receipt and/or proof of consultation?
F2. Has the doctor or nurse of the health unit written a report for the specialist about the reason for the visit?
F3. Have you returned to the health unit with the report on the results of the consultation with the specialist?
F4. Has the doctor or nurse at your health unit talked to you about the results of the consultation with the specialist?
To which health service were you referred? Answer: Y – yes; N – no
F5. Reference center for leprosy
F6. Making of shoes and insoles
F7. Psychology
F8. Physiotherapy
F9. Occupational therapy
F10. Social service
F11. Ophthalmology
F12. Neurology
Continued...
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F13. Orthopedics
F14. Hospital service (Hospital Eduardo de Menezes or Hospital das Clínicas)
FAMILY ORIENTATION
G1. Do you receive home visits from professionals (doctor, nurse, or CHA) of the health unit because of leprosy?
G2. Does the doctor or nurse know who lives with you?
G3. Does the doctor or nurse ask about diseases of other people in your family, such as hypertension, diabetes and cancer?
G4. Does the doctor or nurse ask you if people in your family have spots or areas of the skin with loss or decreased sensitivity?
G5. Do health professionals (doctor, nurse, or CHA) guide you and your family about the examination of the family?
G6. Do health professionals (doctor, nurse, or CHA) talk to people in your family about leprosy?
G7. Does the doctor or nurse ask a person from your family to accompany you on the routine of your treatment?
G8. Do health professionals (doctor, nurse, or CHA) talk with people who live with you about the care you need to have with your eyes, hands and 
feet?
G9. Do health professionals (doctor, nurse, or CHA) talk with people who live with you about the possibility of appearance of new spots, lumps 
and nerve pain during or after the treatment of leprosy?
Only answer the question G10 if you were discharged for healing. Does not apply in other cases.
G10. Do health professionals (doctor, nurse, or CHA) talk with people who live with you about the care after discharge for healing?
COMMUNITY ORIENTATION
H1. Have you seen stories on leprosy in television, radio and newspapers?
H2. Does the health unit organize lectures and give pamphlets to inform the community about leprosy?
H3. Do schools and churches disseminate information on leprosy to the community?
H4. Does the health unit carry out activities in the community to identify people who have spots (Ex: spot day)?
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